Search Results 1751-1760 of 19146 for Enzyme

1. Fluvastatin (oral route) - Side effects & dosage - Mayo Clinic

   It works to reduce the amount of cholesterol in the blood by blocking an enzyme that is needed to make cholesterol. This medicine is available only with ...

2. Treatment of an Inherited Ventricular Arrhythmia - Mayo Clinic

   Any drugs known to be significant inducers or inhibitors of CYP2C8 enzymes for 28 days prior to the first dose of study drug and throughout the study. Any ...

3. Research confirms the clinical characteristics of ocular sarcoidosis

   Visual acuity at diagnosis and at last follow-up; Angiotensin-converting enzyme (ACE) level and serum calcium level at diagnosis; Treatment and response to ...

4. Cholic acid (oral route) - Mayo Clinic

   Cholic acid is a bile acid used to treat patients with bile acid synthesis disorders caused by single enzyme defects. This medicine is also used to help ...

5. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet know whether hormone therapy is more ...

6. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant - Mayo Clinic

   participant is not receiving steroids and/or enzyme inducing anti-epileptic medications for brain metastases. Participants with an established diagnosis of ...

7. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, And The Combinations Of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) In Women With Recurrent, Persistent Or Metastatic Endometrial Cancer. A Multi-Arm Trial For Women With Recurrent Or Persistent Endometrial Cancer” - Mayo Clinic

   Olaparib, cediranib maleate, and Wee1 inhibitor AZD1775 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

8. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant eligibility ...

9. Publications - Jessica R. Wilson, M.D. - Mayo Clinic

   ... Enzyme) Inhibitor Treatment. Hypertension. 2022 Apr; 79 (4):827-835 Epub 2022 Jan 20. View PubMed; Eom YS, Wilson JR, Bernet VJ. Links between Thyroid ...

10. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...